Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 236694011000036114 | Replagal 3.5 mg/3.5 mL concentrated injection, 3.5 mL vial | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| 236696011000036118 | Replagal (agalsidase alfa 3.5 mg / 3.5 mL) concentrated injection, 1 x 3.5 mL vial (trade product pack) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| 2959541000168113 | Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2959551000168110 | Replagal (agalsidase alfa 3.5 mg / 3.5 mL) injection, 1 x 3.5 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | Is a | agalsidase alfa 3.5 mg/3.5 mL injection, 3.5 mL vial | true | Inferred relationship | Some | ||
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | has TPUU | Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | true | Inferred relationship | Some | 1 | |
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | has TP | Replagal | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | Is a | True | Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR